Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
Espańa
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Green Energie
In Vino Veritas
The Vegan Market
French state ownership
Education
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Green Energie
In Vino Veritas
The Vegan Market
French state ownership
Education
Water
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Nasdaq
>
Sage Therapeutics, Inc.
SAGE
SAGE THERAPEUTICS, INC.
(SAGE)
Add to my list
Report
Delayed Nasdaq -
03/04 04:00:01 pm
70.65
USD
-7.25%
03/02
SAGE THERAPEUTICS
: Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83, Maintains Equal Weight Rating
MT
02/26
SAGE THERAPEUTICS
: Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Sets $81 Price Target
MT
02/25
SAGE THERAPEUTICS
: Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, Maintains Outperform Rating
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about SAGE THERAPEUTICS, INC.
03/02
SAGE THERAPEUTICS
: Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..
MT
02/26
SAGE THERAPEUTICS
: Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..
MT
02/25
SAGE THERAPEUTICS
: Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..
MT
02/25
SAGE THERAPEUTICS
: RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..
MT
02/24
SAGE THERAPEUTICS
: Swings to Profit, Posts Higher Revenue in Q4
MT
02/24
SAGE THERAPEUTICS
: Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/24
SAGE THERAPEUTICS
: Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue ..
MT
02/11
SAGE THERAPEUTICS
: to Present at Upcoming Investor Conferences
BU
02/10
SAGE THERAPEUTICS
: to Report Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/02
SAGE THERAPEUTICS
: Raymond James Reinstates Sage Therapeutics at Market Perfor..
MT
01/22
SAGE THERAPEUTICS
: BMO Capital Downgrades Sage Therapeutics to Market Perform ..
MT
01/19
SAGE THERAPEUTICS
: Wedbush Adjusts Price Target on Sage Therapeutics to $98 Fr..
MT
01/07
SAGE THERAPEUTICS
: Provides 2021 Corporate Strategy Update at J.P. Morgan Heal..
BU
01/04
SAGE THERAPEUTICS
: Guggenheim Upgrades Sage Therapeutics to Buy From Neutral, ..
MT
01/04
SAGE THERAPEUTICS
: RBC Downgrades Sage Therapeutics to Sector Perform From Out..
MT
More most relevant news
All news about SAGE THERAPEUTICS, INC.
03/02
SAGE THERAPEUTICS
: Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..
MT
02/26
SAGE THERAPEUTICS
: Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..
MT
02/25
SAGE THERAPEUTICS
: Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..
MT
02/25
SAGE THERAPEUTICS
: RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..
MT
02/24
SAGE THERAPEUTICS
: Swings to Profit, Posts Higher Revenue in Q4
MT
02/24
SAGE THERAPEUTICS
: Management's Discussion and Analysis of Financial Condition..
AQ
02/24
SAGE THERAPEUTICS, INC.
: Results of Operations and Financial Condition, Financ..
AQ
02/24
SAGE THERAPEUTICS
: Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/24
SAGE THERAPEUTICS
: Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue ..
MT
02/11
SAGE THERAPEUTICS
: to Present at Upcoming Investor Conferences
BU
More news
News in other languages on SAGE THERAPEUTICS, INC.
2019
Wall Street finit en hausse après une séance hésitante
2019
SAGE THERAPEUTICS, INC.
: massacre en vue à Wall Street
2019
AVIS D'ANALYSTES DU JOUR
: Air France, BNP Paribas, Teleperformance, DBV Techno..
2019
STOCK MARKET PARIS
: La Fed choisit la sobriété
2019
STOCK MARKET PARIS
: Et si l'Allemagne aidait la BCE à relancer la croissance ?
2019
EN DIRECT DES MARCHES
: Air France KLM, Renault, Vallourec, Scor, Google, Rep..
2019
BB Biotech creuse sa perte au deuxième trimestre
2019
AVIS D'ANALYSTES DU JOUR
: Accor, ArcelorMittal, Danone, Novartis, Sika, Sunris..
2019
STOCK MARKET PARIS
: La Chine met les Terres Rares dans la balance
2019
AVIS D'ANALYSTES DU JOUR
: Hermès, Lagardère, Maurel & Prom, Michelin, TechnipF..
More news
Analyst Recommendations on SAGE THERAPEUTICS, INC.
03/02
SAGE THERAPEUTICS
: Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..
MT
02/26
SAGE THERAPEUTICS
: Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..
MT
02/25
SAGE THERAPEUTICS
: Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..
MT
02/25
SAGE THERAPEUTICS
: RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..
MT
02/02
SAGE THERAPEUTICS
: Raymond James Reinstates Sage Therapeutics at Market Perfor..
MT
More recommendations
Press releases
02/24
SAGE THERAPEUTICS
: Management's Discussion and Analysis of Financial Condition..
AQ
02/24
SAGE THERAPEUTICS, INC.
: Results of Operations and Financial Condition, Financ..
AQ
02/24
SAGE THERAPEUTICS
: Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/11
SAGE THERAPEUTICS
: to Present at Upcoming Investor Conferences
BU
02/10
SAGE THERAPEUTICS
: to Report Fourth Quarter and Full Year 2020 Financial Resul..
BU
More press releases
Powered by Scoopnest.com
Upcoming event on SAGE THERAPEUTICS, INC.
05/06/21
Q1 2021 Earnings Release (Projected)
Company calendar
Upcoming sector events
03/10/21
TG THERAPEUTICS, INC.
:
03/16/21
DENALI THERAPEUTICS INC.
:
03/18/21
ALLAKOS INC.
:
03/25/21
EVOTEC SE
:
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research
Master